Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_assertion type Assertion NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_head.
- NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_assertion description "[Patients with HPV+ OPSCC have an excellent prognosis after radiochemotherapy, but cisplatin-based chemotherapy may not confer a satisfactory outcome, especially in WT cases, thereby justifying the additional or alternative use of taxanes and epidermal gro]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_provenance.
- NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_assertion evidence source_evidence_literature NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_provenance.
- NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_assertion SIO_000772 19577857 NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_provenance.
- NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_assertion wasDerivedFrom gad-20150221 NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_provenance.
- NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_assertion wasGeneratedBy ECO_0000203 NP148252.RAcaVPiXJEHjd7uBmihTPO-ZUBaGDPioL0u-cp3R6ulls130_provenance.